ClinicalTrials.govpublic full text
A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer
non-small cell lung cancer stage iv, patient reported outcomes (pro), patient focused outcomes (pfo), biomarkers, cdk 4 and 6, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 909765
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.